Abstract
The study aimed to describe the prevalence of sarcopenia and discussed the applicability of different diagnostic criteria in Chinese older adults. 286 Chinese adults (136 men and 150 women) aged 60–88 were recruited. The prevalence of sarcopenia were calculated using different diagnostic criteria. Physical functioning was compared in sarcopenic and non-sarcopenic older adults. Compared with the standard of EWGSOP (European Working Group on Sarcopenia in Older People), the prevalence of sarcopenia was higher when the IWGS (International Working Group on Sarcopenia) standard was applied (Men: 7.4% vs. 0.8%; Women: 4.7% vs. 0%). If the AWGS (Aisa Working Group on Sarcopenia) standard was applied, the prevalence was 5.9% in men and 0.7% in women. In conclusion, the prevalence of sarcopenia in Chinese older adults ranged from 0% to around 10% when the diagnostic criteria of IGWS, EWGSOP and AGWS were applied. Further studies are still needed to investigate appropriate diagnostic criterion of sarcopenia for Chinese population.
Key words: Sarcopenia, aging, diagnostic criterion, chinese
Introduction
Sarcopenia, which is characterized by the decreased skeletal muscle mass and strength associated with aging, may lead to serious consequences, such as falls, fractures, physical disability and increased mortality (1, 2). The reported prevalence of sarcopenia in different regions ranged from about 10% to 50%, due to differences in the operational definition of sarcopenia, measurement techniques and study population (3, 4). Most studies in Asian populations showed that the prevalence of sarcopenia was lower than in white populations. In Hong Kong, 12.3% Chinese men and 7.6% women were found to be sarcopenic (5). The prevalence of sarcopenia in Korean older adults was 0.1% to around 10% using different criteria (6). Our previous study showed that very few Chinese adults could be classified as having sarcopenia (7).
A sarcopenia index proposed by Baumgartner and his colleagues defined sarcopenia as relative appendicular skeletal muscle mass (RASM) being two standard deviations or lower than the mean of a healthy reference population (8). Using this index, Chinese adults were found to have approximately 15% lower RASM than their Western counterparts, which would suggest lower cutoff points and lower prevalence of sarcopenia (5, 7). However, lower prevalence of sarcopenia using this definition may not be associated with better strength and physical performance and lower disability, morbidity and mortality. Therefore, the widely-used definition for sarcopenia maybe not fit for Chinese older adults. In recent years, the European Working Group on Sarcopenia in Older People (EWGSOP), the International Working Group on Sarcopenia (IWGS) and Asia Working Group on Sarcopenia (AWGS) recommended their respective consensus definitions (9, 10, 11). The three working groups attached great importance to physical function and muscle strength. Several studies have investigated the prevalence of sarcopenia in different regions using the new consensus definitions (6, 12, 13). However, few studies reported the prevalence of sarcopenia using the new criteria in the Chinese older population.
Therefore, the purpose of this study is to describe the prevalence of sarcopenia and discuss the applicability of different diagnostic criteria in Chinese older adults.
Methods
Study Design and Participants
The data of this study came from a cross-sectional study on body composition in Chinese older adults at Hangzhou, Zhejiang Province in China in June 2013. Older adults aged at least 60 years old from 30 communities in Hangzhou were randomly invited to attend this research project. Ten participants were recruited from each community, so that a total of 300 older adults participated in this study. Individuals with the following conditions were excluded from the study: 1) unable to communicate with research tester; 2) have physical disability; 3) received medications that may influence their body composition; 4) with a mechanical implant in his/her body. Participants were required to complete a series of tests including body composition, hand grip, gait speed, et al. and a questionnaire about their health status and physical functioning. Two participants with physical disabilities or who have received medications that may influence their body composition were excluded from the survey. Twelve participants were excluded because of incomplete data. Consequently, 286 participants (136 men and 150 women) aged 60-88 were included in the data analysis. Signed informed consent was obtained from all participants prior to the survey. The study was approved by the institutional review board of Zhejiang Institute of Sports Science.
Body Composition
Participants’ whole and regional body lean mass were measured by a Norland XR-800 densitometer machine. Appendicular skeletal muscle mass (ASM) was calculated as the sum of lean mass in arms and legs (14). RASM was calculated based on the equation (RASM =ASM/height2). Skeletal muscle index (SMI) was calculated based on the equation (SMI=100×skeletal muscle mass/body mass)(15).
Muscle strength and gait speed
Hand grip strength was measured by a standard adjustable digital handgrip dynamometer (Beijing Xindong Scientific Instruments Co., LTD, China). Participants were instructed to stand up and exert maximal force with shoulder adducted and neutrally rotated and elbow in full extension. Each participant was allowed to take one test trial, followed by three test measurements for each side, and the maximum value of the dominant hand was used in the data analysis. As was suggested by previous studies (9, 16), hand grip strength lower than 20kg in women and 30kg in men was defined as hand grip weakness. Participants’ gait speed was tested in a 6 meter course. Participants were informed to walk at their usual pace and walking time was timed with a stopwatch. Participants could use a walking aid if they were accustomed to use it. Low gait speed was define as gait speed lower than 0.8 m/s (9).
Physical functioning and other information
Participants’ self-reported physical functioning was measured by the 36-Item Short Form Health Survey (SF-36) questionnaire with the assistance of trained testers. Physical functions tested included jogging, climbing stairs, walking, and some other basic skills which could ensure older people could function independently. The participants who reported to have limitations in a specific activity, regardless of the degree of limitation, were classified as having limitations in the activity. SF-36 demonstrated good validity and reliability and were widely applied in previous studies (17, 18). Participants’ demographic information was collected through a questionnaire.
Sarcopenia Classification
Five sets of criteria were used to indentify sarcopenia in this study. For the RASM method, class I sarcopenia was defined as the participants whose RASM were within one to two SDs below the sex-specific mean of young adults. Class II sarcopenia was defined as the participants whose RASM were lower than two SDs below the sex-specific mean of young adults. The data of the young reference population was based on a nationally representative survey in China (7). Similar to the RASM method, SMI class I sarcopenia was defined as the participants whose SMI were within one to two SDs below the sex-specific mean of young adults. SMI Class II sarcopenia was defined as the participants whose SMI were lower than two SDs below the sex-specific mean of young adults. The IWGS, EWGSOP and AWGS criteria, which include not only skeletal muscle mass but also muscle strength and physical performance, were well introduced by the three working groups (9, 10, 11). RASM of 7.23 kg/m2 for men and 5.67 kg/m2 for women, which were introduced by IGWS and RASM of 7.0 kg/m2 for men and 5.4 kg/m2 for women recommended by AGWS, were used as “absolute” cutoff points in the current study.
Data Analysis
Descriptive statistics (means, SDs and percentages) were used to describe key clinical and demographic characteristics. According to RASM, SMI, IWGS, EWGSOP and AWGS methods, the prevalence of sarcopenia in men and women were calculated respectively. A chi-squared test was applied to compare the percentages of participants having problems in physical functioning in sarcopenic and non-sarcopenic older adults. Logistic regression was applied to determine the odds ratios (OR) of having limitations in physical activities in sarcopenic older adults using non-sarcopenic older adults as reference. The 95% confidence interval (CI) is used to in the data analysis.
Results
A total of 286 participants (136 men and 150 women) were finally included in this study. The age of the study population ranged from 60 to 88 in men and 60 to 79 in women. Descriptive statistics of men and women are summarized in Table 1. Compared with women, men had more lean mass, lower body fat and better strength. However, no significant difference was found in gait speed or percentages of having problems in physical functioning in older men and women.
Table 1.
Characteristics of study population (mean±SD)
| Men, n=136 | Women, n=150 | |
|---|---|---|
| Age (y) | 66.5±4.8 | 65.4±45 |
| Height (cm) | 167.0±5.0* | 1542±5.0* |
| Weight (kg) | 65.4±9.3* | 56.3±9.8* |
| BMI (kg/m2) | 23.4±3.1 | 23.1±5.1 |
| Total lean mass (kg) | 45.4±5.5* | 35.8±4.9* |
| Fat % | 23.7±5.8* | 36.1±5.6* |
| Fat mass (kg) | 16.3±5.2* | 21.8±5.9* |
| ALM (kg) | 22.3±2.9* | 16.4±2.6* |
| RASM (kg/m2) | 8.0±0.9* | 6.9±0.9* |
| SMI | 72.4±5.4* | 60.5±5.4* |
| Hand grip strength | 38.4±7.8* | 23.5±5.9* |
| Poor hand grip strength, % | 12.7* | 23.9* |
| Gait speed | 1.1±0.3 | 1.1±0.26 |
| Gait speed<0.8m/s, % | 13.0 | 7.8 |
| Gait speed<1m/s, % | 42.3 | 32.0 |
| Have limitations in the following activities | ||
| Vigorous activities, % | 76.6 | 79.0 |
| Moderate activities, % | 23.2 | 24.5 |
| Lifting or carrying groceries, % | 23.0 | 25.4 |
| Climbing several flights of stairs, % | 40.8 | 40.6 |
| Bending, kneeling or stooping, % | 41.9 | 43.7 |
| Walking more than one mile, % | 27.0 | 31.2 |
| Bathing or dressing by themselves, % |
7.1 |
5.6 |
Note: *: gender difference p<0.05; Poor hand grip strength: man’s handgrip < 30kg; woman’s handgrip < 20kg; RASM: Relative Appendicular Skeletal Mass, =ASM/height2; SMI: Skeletal Muscle Index, =100×skeletal muscle mass/body mass
As it was showed in Table 2, using the RASM Class II sarcopenia standard (two SDs below the mean value of young adults), the cutoff points for Chinese population were 5.85 kg/m2 and 4.23 kg/m2. As a result, only 0.8% of men and none of women could be classified sarcopenic. The prevalence was increased to 11.4% and 0.7% if one SD standard was applied. Compared with RASM standards, using SMI as indicator, the prevalence of sarcopenia were higher in both men and women (Class II standard Men: 2.2% vs. 0.8%; Women: 7.5% vs. 0%; Class I standard men 22.2% vs. 11.4%, women 51.7% vs. 0.7%).
Table 2.
Prevalence of sarcopenia in Chinese older adults using different diagnostic criteria
| Indicators & standard | Cutoff points | Men n=136 | Women n=150 |
|---|---|---|---|
| RASM Class I sarcopenia | M : RASM=6.91 kg/m2 | 11.4 | 0.7 |
| F : RASM=5.18kg/m2 | |||
| RASM Class II sarcopenia | M : RASM=5.85kg/m2 | 0.8 | 0 |
| F : RASM=4.23kg/m2 | |||
| SMI Class I sarcopenia | M : SMI =69 | 22.2 | 51.7 |
| F : SMI =60.4 | |||
| SMI Class II sarcopenia | M : SMI =61.4 | 2.2 | 7.5 |
| F : SMI =53.4 | |||
| IWGS | M: RASM=7.23 kg/m2 | 7.4 | 4.7 |
| F: RASM=5.67 kg/m2 | |||
| EWGSOP | Gait speed < 1.0 m/s | ||
| M : RASM=5.85kg/m2 | |||
| F : RASM=4.23kg/m2 | |||
| Gait speed < 0.8 m/s | 0.8 | 0 | |
| M : Hand grip strength < 30kg | |||
| F : Hand grip strength< 20kg | |||
| AWGS | M: RASM=7.0 kg/m2 | ||
| F: RASM=5.3 kg/m2 | |||
| Gait speed < 0.8 m/s | 5.9 | 0.7 | |
| M : Hand grip strength < 26kg | |||
| F : Hand grip strength < 18kg |
Note: RASM: relative appendicular skeletal muscle mass; SMI: skeletal muscle index, 100×skeletal muscle mass/body mass; Class I: one SD below the mean value of young adults; Class II: two SDs below the mean value of young adults
Using the IWGS standard gave us a cutoff of 7.23 kg/m2 in men and 5.67 kg/m2 in women, which is higher than the cutoff points of EWGSOP (5.85 kg/m2 in men and 4.23 kg/m2 in women). Therefore, compared with the standard of EWGSOP, the prevalence of sarcopenia in the current study population was higher when the IWGS standard was applied (Men: 7.4% vs. 0.8%; Women: 4.7% vs. 0%). If the AWGS standard was applied, the prevalence of sarcopenia would be 5.9% in men and 0.7% in women.
Percentages of having physical difficulties in sarcopenic and non-sarcopenic older men and women defined by different criteria were summarized in Table 3 and Table 4. The data of percentages using several criteria (e.g. RASM class II) were not presented because prevalence of sarcopenia was very low (< 5%) so that none or only several participants could be included in the calculation. There were no significant difference in the percentages between sarcopenic and non-sarcopenic older adults in most groups using the criteria of RASM, SMI and IWGS. However, using the AWGS standard, significant differences were found in “low hand grip strength”, “low gait speed” and “lifting or carrying groceries” between the sarcopenic and non-sarcopenic men. Significant differences were also found in “low gait speed” and “climbing several flights of stairs” between the sarcopenic and non-sarcopenic women when IWGS standard was used. The results of logistic regression showed that when the AWGS standard was applied, sarcopenic older adults had significant higher odds to have low hand grip strength (OR=16.29, 95%CI: 3.53-75.15) and low gait speed (OR=5.57, 95%CI: 1.27-24.41) when compared with the non-sarcopenic study population (Table 5).
Table 3.
Percentages of having physical difficulties in sarcopenic and non-sarcopenic elder men defined by different criteria
| RASM Class I | SMI Class I | IWGS | AWGS | |||||
|---|---|---|---|---|---|---|---|---|
| Non-sarcopenic | Sarcopenic | Non-sarcopenic | Sarcopenic | Non-sarcopenic | Sarcopenic | Non-sarcopenic | Sarcopenic | |
| N=117 | N=15 | N=105 | N=30 | N=126 | N=10 | N=128 | N=8 | |
| Low hand grip strength | 10.1 | 28.6 | 10.0 | 20.0 | 12.1 | 20.0 | 9.3* | 62.5* |
| Low gait speed | 11.9 | 21.4 | 14.1 | 8.3 | 9.7* | 50.0* | 10.4* | 50.0* |
| Having a little or serious difficulties in | ||||||||
| Vigorous activities | 77.4 | 64.3 | 76.5 | 76.0 | 77.2 | 70.0 | 76.7 | 75.0 |
| Moderate activities | 24.3 | 21.4 | 24.2 | 20.0 | 22.6 | 30.0 | 22.2 | 37.5 |
| Lifting or carrying groceries | 24.1 | 21.4 | 23.2 | 23.1 | 21.6 | 40.0 | 21.2# | 50.0# |
| Climbing several flights of stairs | 42.6 | 28.6 | 40.4 | 42.3 | 41.7 | 30.0 | 39.3 | 62.5 |
| Bending, kneeling or stooping | 44.3 | 28.6 | 46.4 | 26.9 | 41.2 | 50.0 | 42.2 | 37.5 |
| Walking more than one mile | 28.7 | 21.4 | 27.3 | 26.9 | 27.6 | 20.0 | 26.3 | 37.5 |
| Bathing or dressing by themselves |
8.3 |
0 |
8.0 |
3.8 |
6.9 |
10.0 |
7.6 |
0 |
Note: *: p<0.05, #:p<0.10
Table 4.
Percentages of having physical difficulties in sarcopenic and non-sarcopenic elder women defined by different criteria
| SMI Class I | SMI Class II | IWGS | ||||
|---|---|---|---|---|---|---|
| Non-sarcopenic | Sarcopenic | Non-sarcopenic | Sarcopenic | Non-sarcopenic | Sarcopenic | |
| N=71 | N=76 | N=136 | N=11 | N=143 | N=7 | |
| Low hand grip strength | 20.6 | 28.2 | 24.6 | 22.2 | 23.0 | 42.9 |
| Low gait speed | 3.2# | 12.1# | 8.3 | 0.0 | 5.8* | 42.9* |
| Having a little or serious difficulties in | ||||||
| Vigorous activities | 86.6# | 72.6# | 80.8 | 60.0 | 79.4 | 71.4 |
| Moderate activities | 25.4 | 24.6 | 24.6 | 30.0 | 23.5 | 42.9 |
| Lifting or carrying groceries | 28.4 | 23.6 | 25.6 | 30.0 | 25.2 | 28.6 |
| Climbing several flights of stairs | 41.2 | 41.7 | 40.8 | 40.0 | 39.0 # | 71.4 # |
| Bending, kneeling or stooping | 46.3 | 43.1 | 44.7 | 40.0 | 44.4 | 28.6 |
| Walking more than one mile | 37.3 | 26.8 | 32.8 | 20.0 | 30.6 | 42.9 |
| Bathing or dressing by themselves |
4.5 |
7.0 |
5.4 |
10.0 |
5.1 |
14.3 |
Note: *: p<0.05, #:p<0.10
Table 5.
Odds ratios of having physical difficulties in sarcopenic group using non-sarcopenia group as reference
| RASM Class I | SMI Class I | SMI Class II | IWGS | AWGS | |
|---|---|---|---|---|---|
| N=282 | N=282 | N=282 | N=286 | N=282 | |
| Poor hand grip strength | 3.12 (0.86-11.32) | 1.68 (0.86-3.27) | 2.72 (0.73-10.15) | 2.12(0.69-6.54) | 16.29(3.53-75.15) ** |
| Poor gait speed | 2.04 (0.51-8.24) | 1.41 (0.57-3.48) | Not available | 10.38(3.46-31.16) ** | 5.57 (1.27-24.41)** |
| Having a little or serious difficulties in | |||||
| Vigorous activities | 0.59 (0.19-1.86) | 0.60 (0.32-1.15) | 0.40 (0.12-1.30) | 0.66 (0.22-1.96) | 0.95 (0.19-4.89) |
| Moderate activities | 1.16 (0.34-3.92) | 0.91 (0.49-1.69) | 1.37 (0.40-4.65) | 1.84(0.65-5.22) | 1.84 (0.43-7.88) |
| Lifting or carrying groceries | 1.16 (0.35-3.93) | 0.86 (0.47-1.60) | 1.31 (0.38-4.45) | 1.82 (0.64-5.18) | 3.25 (0.80-13.17) |
| Climbing several flights of stairs | 0.67 (0.22-2.09) | 1.05 (0.62-1.80) | 1.21 (0.39-3.73) | 1.32 (0.49-3.57) | 2.10 (0.53-8.32) |
| Bending, kneeling or stooping | 0.45 (0.14-1.49) | 0.70 (0.41-1.20) | 0.76 (0.24-2.42) | 0.94 (0.34-2.56) | 1.23 (0.31-4.87) |
| Walking more than one mile | 0.91 (0.27-3.05) | 0.73 (0.41-1.32) | 0.64 (0.17-2.42) | 1.04 (0.35-3.08) | 1.49 (0.35-6.37) |
| Bathing or dressing by themselves |
Not available |
0.98 (0.33-2.93) |
1.32 (0.16-10.99) |
2.04(0.42-9.79) |
0.79 (0.17-3.73) |
Note: Age and gender were adjusted in the regression, **: p<0.01; The 95% confidence interval (CI) is used to used to estimate the precision of the OR.
Discussion
Using different definitions of sarcopenia, the prevalence of sarcopenia in the current study population was calculated. Similar to the results of previous studies, the results also showed that the prevalence varies greatly with different criteria. The prevalence ranged from 0% to around 10%, except for the prevalence of sarcopenia in women based on SMI method (Class I). The prevalence depended largely on the applied indicators and cutoff points. The cutoff points of RASM applied in the studies in Korea (men:7.40kg/m2, women:5.14kg/m2) (19) and Taiwan (men:7.27kg/m2, women:5.44kg/m2) (20) were roughly equivalent to the ones in the Rosetta study (men:7.26kg/m2, women:5.5kg/m2) (8), Health ABC study (men:7.25kg/m2, women:5.67kg/m2) (21) and in Italy (men:7.59kg/m2, women: 5.47kg/m2) (22). In contrast, the cutoff values in the studies in Hong Kong (men: 5.72kg/m2, women: 4.82kg/m2) (23) and mainland China (men:5.85kg/m2, women:4.23kg/m2) (7) were obviously lower than the other five studies. Racial differences may partly explain the big gap in cutoff points among different study populations. However, the great differences in cutoff scores among East Asian populations make it very hard to compare the prevalence of sarcopenia in Korea, Hong Kong and mainland China. In 2010, experts from EWGSOP reached a consensus on the definition and diagnosis of sarcopenia. Physical performance was emphasized by both of the working groups. However, the evaluation of muscle mass was still based on the normative populations in the criteria of EWGSOP, which means the classification of sarcopenia still depends largely on which cutoff point and reference population is used.
Norm-referenced standards and cutoff points were widely applied in measurement and evaluation practice. When a good young reference population can be achieved, establishing norm-referenced standards and cutoff scores for the diagnosis of sarcopenia is relatively easy. However, one of the limitations of norm-referenced standards is that the interpretation depends on the data of the reference population (24, 25). The application of criterion-referenced standards may help us solve this limitation. Compared with the norm-referenced standards in which the evaluation of a test-taker’s competency was determined relative to the performance of other test-takers, the criterion-referenced standards compares the test-taker’s performance with an absolute criterion (25). Defining sarcopenia based on future risk of physical limitations could be more meaningful when compared using the data of a young reference population directly. In fact, in 2004, Janssen and his colleagues had raised this idea and determined the skeletal muscle cutoff scores related to elevated physical disability risk in older adults (26). The results of that study showed that women with RASM of 5.76-6.75 and ≤5.75 kg/m2 and men with RASM of 8.51-10.75 and ≤8.50 kg/m2 were found to be associated with moderate and high physical disability risk. However, these cutoff points were not widely applied to report the prevalence of sarcopenia, probably because bioimpedance rather than DXA was used to estimate skeletal muscle. A longitudinal study conducted by Woo in 2009 also investigated “absolute” cutoff values in the Chinese population (27). However, a U-shaped instead of linear relationship was found between RASM and physical limitations. The findings were confirmed in their follow-up study (28). Using the data of the present study, a U-shaped relationship between RASM and physical limitation was not found, which could be due to relatively small sample size.
“Absolute” cutoff points recommended by IGWS (RASM of 7.23 kg/m2 for men and 5.67 kg/m2 for women) and AGWS (RASM of 7.0 kg/m2 for men and 5.4 kg/m2 for women) were applied in the current study. The results suggested that, compared with other criteria, AGWS and IGWS standard could discriminate physical limitations such as “lifting or carrying groceries” in men and “climbing several flights of stairs” in women. However, no significant difference was found in other groups. Further studies are still needed to investigate the scientific evidence for the establishment of diagnostic criterion for sarcopenia in Chinese population, which is very important in clinical application.
Several limitations should be acknowledged in this study. One of the major limitations is relatively small sample size. Because of the difficulties in the recruitment of older adults, there were about 300 participants were included and most of them were no more than 75 years old. In addition, the study was conducted in Hangzhou and not nationally representative data. Nevertheless, the study still provides some valuable data for the establishing diagnostic criteria of sarcopenia for Asian older adults.
In conclusion, the prevalence of sarcopenia in Chinese older adults ranged from 0% to around 10% when the diagnostic criteria of IGWS, EWGSOP and AGWS were applied. Further studies are still needed to investigate appropriate diagnostic criterion of sarcopenia for Chinese population.
Conflict of interest: This study is based upon work funded by Zhejiang Provincial Natural Science Foundation of China under Grant No. LQ12C11001 and Research Project of Sports Bureau of Zhejiang Province 2103.
Ethical standards: All of the authors have compiled with the “Principles of the Ethical Practice of Public Health,” as outlined in A Code of Ethics for Public Health Thomas, et al. The study was approved by the institutional review board of Zhejiang Institute of Sports Science.
Acknowledgement: Assistance in English writing provided by Joshua Bocher, the Coordinator for the Asian Diabetes Prevention Initiative Website, was greatly appreciated.
References
- 1.Van Kan GA. Epidemiology and consequences of sarcopenia. J Nutr Health Aging. 2009;13:708–712. doi: 10.1007/s12603-009-0201-z. 10.1007/s12603-009-0201-z [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Arango-Lopera VE, Arroyo P, Gutierrez-Robledo L, Perez-Zepeda MU, Cesari M. Mortality as an adverse outcome of sarcopenia. J Nutr Health Aging. 2013;17:259–262. doi: 10.1007/s12603-012-0434-0. 10.1007/s12603-012-0434-0 PubMed PMID: 23459979. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Bijlsma AY, Meskers CGM, Ling CHY, Narici M, Kurrle SE, Cameron ID, Westendorp RGJ, Maier AB. Defining sarcopenia: The impact of different diagnostic criteria on the prevalence of sarcopenia in a large middle aged cohort. AGE. 2012;35:871–881. doi: 10.1007/s11357-012-9384-z. 10.1007/s11357-012-9384-z PMCID 3636407. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Alexandre TS, Duarte YAO, Santos JLF, Wong R, Lebrao ML. Prevalence and associated factors of sarcopenia among elderly in brazil: Findings from the sabe study. J Nutr Health Aging. 2014;18:284–290. doi: 10.1007/s12603-013-0413-0. 10.1007/s12603-013-0413-0 [DOI] [PubMed] [Google Scholar]
- 5.Lau EMC, Lynn HSH, Woo JW, Kwok TCY, Melton LJI. Prevalence of and risk factors for sarcopenia in elderly chinese men and women. J Gerontol A Biol Sci Med Sci. 2005;60:213–216. doi: 10.1093/gerona/60.2.213. 10.1093/gerona/60.2.213 PubMed PMID: 15814865. [DOI] [PubMed] [Google Scholar]
- 6.Kim Y-S, Lee Y, Chung Y-S, Lee D-J, Joo N-S, Hong D, Song G, Kim H-J, Choi YJ, Kim K-M. Prevalence of sarcopenia and sarcopenic obesity in the korean population based on the fourth korean national health and nutritional examination surveys. J Gerontol A Biol Sci Med Sci. 2012;67:1107–1113. doi: 10.1093/gerona/gls071. 10.1093/gerona/gls071 PubMed PMID: 22431554. [DOI] [PubMed] [Google Scholar]
- 7.Wen X, Wang M, Jiang CM, Zhang YM. Are current definitions of sarcopenia applicable for older chinese adults. J Nutr Health Aging. 2011;15:847–851. doi: 10.1007/s12603-011-0088-3. 10.1007/s12603-011-0088-3 PubMed PMID: 22159771. [DOI] [PubMed] [Google Scholar]
- 8.Baumgartner RN, Koehler KM, Gallagher D, Romero L, Heymsfield SB, Ross RR, Garry PJ, Lindeman RD. Epidemiology of sarcopenia among the elderly in new mexico. Am J Epidemiol. 1998;147:755–763. doi: 10.1093/oxfordjournals.aje.a009520. 10.1093/oxfordjournals.aje.a009520 PubMed PMID: 9554417. [DOI] [PubMed] [Google Scholar]
- 9.Cruz-Jentoft AJ, Baeyens JP, Bauer JM, Boirie Y, Cederholm T, Landi F, Martin FC, Michel JP, Rolland Y, Schneider SM, Topinková E, Vandewoude M, Zamboni M. Sarcopenia: European consensus on definition and diagnosis. Report of the European working group on sarcopenia in older people. Age Ageing. 2010;39:412–423. doi: 10.1093/ageing/afq034. 10.1093/ageing/afq034 PMCID 2886201; PubMed PMID: 20392703. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Fielding RA, Vellas B, Evans WJ, Bhasin S, Morley JE, Newman AB, van Abellan K G, Andrieu S, Bauer J, Breuille D, Cederholm T, Chandler J, De Meynard C, Donini L, Harris T, Kannt A, Keime G F, Onder G, Papanicolaou D, Rolland Y, Rooks D, Sieber C, Souhami E, Verlaan S, Zamboni M. Sarcopenia: An undiagnosed condition in older adults. Current consensus definition: Prevalence, etiology, and consequences. International working group on sarcopenia. J Am Med Dir Assoc. 2011;12:249–256. doi: 10.1016/j.jamda.2011.01.003. 10.1016/j.jamda.2011.01.003 PubMed PMID: 21527165. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Chen L-K, Liu L-K, Woo J, Assantachai P, Auyeung T-W, Bahyah KS, Chou M-Y, Chen L-Y, Hsu P-S, Krairit O, Lee JSW, Lee W-J, Lee Y, Liang C-K, Limpawattana P, Lin C-S, Peng L-N, Satake S, Suzuki T, Won CW, Wu C-H, Wu S-N, Zhang T, Zeng P, Akishita M, Arai H. Sarcopenia in Asia: Consensus report of the Asian working group for sarcopenia. J Am Med Dir Assoc. 2014;15:95–101. doi: 10.1016/j.jamda.2013.11.025. 10.1016/j.jamda.2013.11.025 PubMed PMID: 24461239. [DOI] [PubMed] [Google Scholar]
- 12.Volpato S, Bianchi L, Cherubini A, Landi F, Maggio M, Savino E, Bandinelli S, Ceda GP, Guralnik JM, Zuliani G, Ferrucci L. Prevalence and clinical correlates of sarcopenia in community-dwelling older people: Application of the EWGSOP definition and diagnostic algorithm. J Gerontol A Biol Sci Med Sci. 2014;69:438–446. doi: 10.1093/gerona/glt149. 10.1093/gerona/glt149 PubMed PMID: 24085400. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Patel HP, Syddall HE, Jameson K, Robinson S, Denison H, Roberts HC, Edwards M, Dennison E, Cooper C, Aihie S A. Prevalence of sarcopenia in community-dwelling older people in the uk using the European working group on sarcopenia in older people (EWGSOP) definition: Findings from the hertfordshire cohort study (hcs) Age Ageing. 2013;42:378–384. doi: 10.1093/ageing/afs197. 10.1093/ageing/afs197 PMCID 3633365; PubMed PMID: 23384705. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Delmonico MJ, Harris TB, Lee JS, Visser M, Nevitt M, Kritchevsky SB, Tylavsky FA, Newman AB. Health Aging and Body Composition Study. Alternative definitions of sarcopenia, lower extremity performance, and functional impairment with aging in older men and women. J Am Geriatr Soc. 2007;55:769–774. doi: 10.1111/j.1532-5415.2007.01140.x. 10.1111/j.1532-5415.2007.01140.x PubMed PMID: 17493199. [DOI] [PubMed] [Google Scholar]
- 15.Janssen I, Heymsfield SB, Ross R. Low relative skeletal muscle mass (sarcopenia) in older persons is associated with functional impairment and physical disability. J Am Geriatr Soc. 2002;50:889–896. doi: 10.1046/j.1532-5415.2002.50216.x. 10.1046/j.1532-5415.2002.50216.x PubMed PMID: 12028177. [DOI] [PubMed] [Google Scholar]
- 16.Lauretani F, Russo CR, Bandinelli S, Bartali B, Cavazzini C, Di Iorio A, Corsi AM, Rantanen T, Guralnik JM, Ferrucci L. Age-associated changes in skeletal muscles and their effect on mobility: An operational diagnosis of sarcopenia. J Appl Physiol. 2003;95:1851–1860. doi: 10.1152/japplphysiol.00246.2003. 10.1152/japplphysiol.00246.2003 PubMed PMID: 14555665. [DOI] [PubMed] [Google Scholar]
- 17.Walters SJ, Munro JF, Brazier JE. Using the sf-36 with older adults: A cross-sectional community-based survey. Age Ageing. 2001;30:337–343. doi: 10.1093/ageing/30.4.337. 10.1093/ageing/30.4.337 PubMed PMID: 11509313. [DOI] [PubMed] [Google Scholar]
- 18.Qu B, Guo H, Liu J, Zhang Y, Sun G. Reliability and validity testing of the sf-36 questionnaire for the evaluation of the quality of life of chinese urban construction workers. J Int Med Res. 2009;37:1184–1190. doi: 10.1177/147323000903700425. 10.1177/147323000903700425 PubMed PMID: 19761703. [DOI] [PubMed] [Google Scholar]
- 19.Kim TN, Yang SJ, Yoo HJ, Lim KI, Kang HJ, Song W, Seo JA, Kim SG, Kim NH, Baik SH, Choi DS, Choi KM. Prevalence of sarcopenia and sarcopenic obesity in korean adults: The korean sarcopenic obesity study. Int J Obes. 2009;33:885–892. doi: 10.1038/ijo.2009.130. 10.1038/ijo.2009.130 [DOI] [PubMed] [Google Scholar]
- 20.Lee WJ, Liu LK, Peng LN, Lin MH, Chen LK. Comparisons of sarcopenia defined by IWGS and EWGSOP criteria among older people: Results from the i-lan longitudinal aging study. J Am Med Dir Assoc. 2013:10–14. doi: 10.1016/j.jamda.2013.03.019. [DOI] [PubMed] [Google Scholar]
- 21.Newman AB, Kupelian V, Visser M, Simonsick E, Goodpaster B, Nevitt M, Kritchevsky SB, Tylavsky FA, Rubin SM, Harris TB, Health ABC Study Investigators Sarcopenia: Alternative definitions and associations with lower extremity function. J Am Geriatr Soc. 2003;51:1602–1609. doi: 10.1046/j.1532-5415.2003.51534.x. 10.1046/j.1532-5415.2003.51534.x PubMed PMID: 14687390. [DOI] [PubMed] [Google Scholar]
- 22.Coin A, Sarti S, Ruggiero E, Giannini S, Pedrazzoni M, Minisola S, Rossini M, Del Puente A, Inelmen EM, Manzato E, Sergi G. Prevalence of sarcopenia based on different diagnostic criteria using DEXA and appendicular skeletal muscle mass reference values in an Italian population aged 20 to 80. J Am Med Dir Assoc. 2013;14:507–512. doi: 10.1016/j.jamda.2013.02.010. 10.1016/j.jamda.2013.02.010 PubMed PMID: 23582341. [DOI] [PubMed] [Google Scholar]
- 23.Lau EMC, Lynn HSH, Woo JW, Kwok TCY, Melton LJ., III Prevalence of and risk factors for sarcopenia in elderly Chinese men and women. J Gerontol A Biol Sci Med Sci. 2005;60:213–216. doi: 10.1093/gerona/60.2.213. 10.1093/gerona/60.2.213 PubMed PMID: 15814865. [DOI] [PubMed] [Google Scholar]
- 24.Zhu W. Science and art of setting performance standards and cutoff scores in kinesiology. Res Q Exerc Sport. 2013;84:456–468. doi: 10.1080/02701367.2013.845517. 10.1080/02701367.2013.845517 PubMed PMID: 24592776. [DOI] [PubMed] [Google Scholar]
- 25.Zhu W, Mahar MT, Welk GJ, Going SB, Cureton KJ. Approaches for development of criterion-referenced standards in health-related youth fitness tests. Am J Prev Med. 2011;41:S68–S76. doi: 10.1016/j.amepre.2011.07.001. 10.1016/j.amepre.2011.07.001 PubMed PMID: 21961615. [DOI] [PubMed] [Google Scholar]
- 26.Janssen I, Baumgartner RN, Ross R, Rosenberg IH, Roubenoff R. Skeletal muscle cutpoints associated with elevated physical disability risk in older men and women. Am J Epidemiol. 2004;159:413–421. doi: 10.1093/aje/kwh058. 10.1093/aje/kwh058 PubMed PMID: 14769646. [DOI] [PubMed] [Google Scholar]
- 27.Woo J, Leung J, Sham A, Kwok T. Defining sarcopenia in terms of risk of physical limitations: A 5-year follow-up study of 3,153 Chinese men and women. J Am Geriatr Soc. 2009;57:2224–2231. doi: 10.1111/j.1532-5415.2009.02566.x. 10.1111/j.1532-5415.2009.02566.x PubMed PMID: 19925615. [DOI] [PubMed] [Google Scholar]
- 28.Auyeung TW, Lee JS, Leung J, Kwok T, Woo J. Adiposity to muscle ratio predicts incident physical limitation in a cohort of 3,153 older adults—an alternative measurement of sarcopenia and sarcopenic obesity. AGE. 2013;35:1377–1385. doi: 10.1007/s11357-012-9423-9. 10.1007/s11357-012-9423-9 PMCID 3705102; PubMed PMID: 22614096. [DOI] [PMC free article] [PubMed] [Google Scholar]
